Oncternal Therapeutics Inc Working Capital to Net Assets Ratio
Oncternal Therapeutics Inc working capital to net assets ratio. Oncternal Therapeutics Inc (ONCT) has a Working Capital to Net Assets ratio of 98.3% as of September 2024. Working capital of $8.99 Million (current assets of $15.45 Million minus current liabilities of $6.45 Million) is measured against net assets of $9.15 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ONCT goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Oncternal Therapeutics Inc (2002–2023)
Working capital to net assets ratio of Oncternal Therapeutics Inc from 2002 to 2023. This chart shows how Oncternal Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2002 to 2023. As of September 2024, the ratio stands at 98.3%, reflecting working capital of $8.99 Million against net assets of $9.15 Million USD. See Oncternal Therapeutics Inc (ONCT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Oncternal Therapeutics Inc Working Capital to Net Assets Ratio by Year (2002–2023)
Oncternal Therapeutics Inc working capital to net assets ratio by year from 2002 to 2023. The table below presents the year-by-year Working Capital to Net Assets ratio for Oncternal Therapeutics Inc from 2002 to 2023, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Oncternal Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 102.7% | $30.86 Million | $30.05 Million | $36.06 Million | $5.20 Million | ▲ +4.9 pp |
| 2022 | 97.8% | $59.61 Million | $60.97 Million | $67.29 Million | $7.68 Million | ▼ -1.4 pp |
| 2021 | 99.2% | $87.39 Million | $88.12 Million | $92.85 Million | $5.46 Million | ▼ -0.1 pp |
| 2020 | 99.3% | $112.14 Million | $112.95 Million | $118.00 Million | $5.86 Million | ▲ +5.3 pp |
| 2019 | 93.9% | $13.45 Million | $14.31 Million | $20.79 Million | $7.34 Million | ▼ -5.6 pp |
| 2018 | 99.6% | $26.00 Million | $26.11 Million | $31.21 Million | $5.21 Million | ▼ 0.0 pp |
| 2017 | 99.6% | $38.10 Million | $38.26 Million | $46.08 Million | $7.97 Million | ▲ +0.6 pp |
| 2016 | 99.0% | $19.69 Million | $19.89 Million | $24.30 Million | $4.61 Million | ▲ +6.6 pp |
| 2015 | 92.4% | $1.72 Million | $1.86 Million | $31.89 Million | $30.17 Million | ▼ -5.0 pp |
| 2014 | 97.4% | $17.36 Million | $17.83 Million | $50.15 Million | $32.79 Million | ▼ -1.9 pp |
| 2013 | 99.3% | $10.60 Million | $10.68 Million | $15.17 Million | $4.57 Million | ▲ +0.0 pp |
| 2012 | 99.2% | $47.32 Million | $47.70 Million | $56.81 Million | $9.49 Million | ▲ +0.7 pp |
| 2011 | 98.5% | $70.77 Million | $71.87 Million | $76.85 Million | $6.08 Million | ▼ -8.0 pp |
| 2010 | 106.4% | $55.05 Million | $51.73 Million | $60.36 Million | $5.30 Million | ▲ +503.3 pp |
| 2009 | -396.8% | $34.72 Million | $-8.75 Million | $50.67 Million | $15.95 Million | ▼ -643.7 pp |
| 2008 | 246.9% | $79.05 Million | $32.02 Million | $100.02 Million | $20.98 Million | ▲ +78.4 pp |
| 2007 | 168.4% | $132.93 Million | $78.92 Million | $152.26 Million | $19.33 Million | ▲ +53.7 pp |
| 2006 | 114.7% | $111.36 Million | $97.05 Million | $121.70 Million | $10.34 Million | ▲ +19.6 pp |
| 2005 | 95.2% | $70.03 Million | $73.58 Million | $76.00 Million | $5.97 Million | ▼ -0.7 pp |
| 2004 | 95.9% | $61.30 Million | $63.91 Million | $66.15 Million | $4.85 Million | ▲ +104.4 pp |
| 2003 | -8.5% | $12.78 Million | $-150.23 Million | $15.02 Million | $2.25 Million | ▲ +5.3 pp |
| 2002 | -13.8% | $7.65 Million | $-55.31 Million | $8.97 Million | $1.31 Million | — |